LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION

NCT04409275 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-06-11

No results posted yet for this study

Summary

Prospective, observational, multicenter study that will evaluate the changes in lung function that patients admitted with SARS-CoV-2 pneumonia will present according to the level of severity at 4, 12, 26 and 52 weeks after hospital discharge.

Conditions

Sponsors & Collaborators

  • Fundación para la Investigación del Hospital Clínico de Valencia

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-21
Primary Completion
2020-12-31
Completion
2021-07-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04409275 on ClinicalTrials.gov